Related Experiment Video
Updated: Apr 29, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Calcium nephrolithiasis induced by topiramate
Sergio Merino-Salas1, Miguel Angel Arrabal-Polo2, Maria del Carmen Cano-Garcia3
1Servicio de Urologia.Hospital de Poniente.El Ejido.Almeria. Spain.
Topiramate can cause kidney stones (nephrolithiasis) in women, often due to metabolic changes like alkaline urine and low citrate. Monitoring and preventative measures are crucial for patients on this medication.
Area of Science:
- Neurology
- Nephrology
- Pharmacology
Background:
- Topiramate, an anticonvulsant, is increasingly used for neurological conditions and chronic pain management.
- Its efficacy in pain and mood stabilization is recognized, but potential side effects require attention.
Observation:
- Four cases of topiramate-induced nephrolithiasis in women treated for pain and mood stabilization (250-300 mg/day) were observed between 2006-2012.
- The kidney stones were composed of calcium phosphate (apatite) and/or oxalate.
- Metabolic alterations included alkaline urine pH and hypocitraturia.
Findings:
- Topiramate treatment was associated with the development of nephrolithiasis.
- Alkaline urine and hypocitraturia were the most frequent metabolic disturbances.
- Mixed tubular acidosis is a potential risk factor.
Implications:
- Patients initiating topiramate therapy require proactive monitoring for nephrolithiasis.
- Preventative strategies, including increased fluid and potassium citrate intake, may mitigate risks.
- Understanding these risks is vital for safe and effective topiramate use in pain and mood management.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi I: Introduction
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi V: Nursing Management

